The role of MCPIP1 protein in growth, progression and vascularisation of clear cell renal cell carcinoma.
2015/19/B/NZ5/01405
Keywords
Descriptors
- NZ5_7: Leczenie chorób człowieka
- NZ5_3: Patogeneza chorób człowieka
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 7
Call
OPUS 10 – announced on 2015-09-15
- Amount awarded
- 788 400 PLN
- Project start date
- 2016-06-23
- Project end date
- 2021-06-22
- Project duration
- 60 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- cytometr przepływowy. Cost: 160 000 PLN
- komputer. Cost: 5 000 PLN
- lodówka. Cost: 3 000 PLN
Information in the final report
Publication in academic press/journals (4)
-
C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
- Authors:
- Paulina Marona , Judyta Górka, Jerzy Kotlinowski, Marcin Majka , Jolanta Jura, Katarzyna Miekus
- Academic press:
- Cells (year: 2019, volume: 272, pages: 8; MDPI używa nr artykułów, zamiast nr stron), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/cells8030272 – link to the publication
-
MCPIP1 downregulation in clear cell renal cell carcinoma promotes vascularization and metastatic progression
- Authors:
- Marona P, Górka J., Mazurek Z, Wilk W, Rys J, Majka M, Jura J, Miekus K
- Academic press:
- Cancer Research (year: 2017, volume: Sep 15;77(18), pages: 4905-4920), Publisher: AACR
- Status:
- Published
- DOI:
- 10.1158/0008-5472 – link to the publication
-
The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors
- Authors:
- Judyta Gorka, Paulina Marona, Oliwia Kwapisz, Janusz Rys, Jolanta Jura, Katarzyna Miekus
- Academic press:
- European Journal of Pharmacology (year: 2020, volume: 888, pages: 173591), Publisher: Elsevier
- Status:
- Published
-
MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs
- Authors:
- Judyta Gorka, Paulina Marona, Oliwia Kwapisz, Agnieszka Waligórska, Ewelina Pospiech, Jurek W Dobrucki, Janusz Rys, Jolanta Jura, Katarzyna Miekus
- Academic press:
- Oncogene (year: 2021, volume: 50, pages: 6720-6735), Publisher: Nature Publishing Group
- Status:
- Published
- DOI:
- 10.1038/s41388-021-02062-3 – link to the publication
Articles in post-conference publications (1)
-
RNase activity of MCPIP1 regulates key elements of mesenchymal phenotype of clear cell renal cell carcinoma cells
- Authors:
- Miekus, K; Marona, P ; Gorka, J; Jura, J
- Conference:
- Annual Meeting of the American-Association-for-Cancer-Research (AACR) (year: 2018, pages: Volume: 78 Issue: 13, S Meeting Abstract: 5003), Publisher: Cancer Research
- Date:
- conference APR 14-18, 2018
- Status:
- Published
- DOI:
- link to the publication